The National Asthma Council Australia today released an update to its popular Allergic Rhinitis Treatments Chart.
The chart provides a visual reference tool to help health professionals explain the range and types of nasal treatments available for allergic rhinitis, which affects about three in four people with asthma.
National Asthma Council CEO Siobhan Brophy says achieving good asthma control is particularly important during the COVID-19 pandemic.
“It’s more important than ever for health professionals to help patients manage their asthma, so their respiratory system is in the best possible shape should they encounter an infection like COVID-19 or seasonal influenza,” Ms Brophy says.
“Poorly managed allergic rhinitis can make asthma more difficult to control. A comprehensive approach to asthma management includes investigation for allergic rhinitis and effective treatment.”
The latest version of the Allergic Rhinitis Treatments Chart includes the main nasal treatment options available in Australia.
Health professionals can download free copies of the chart from the National Asthma Council website, along with a suite of resources to help manage allergic rhinitis and asthma including the Allergic Rhinitis Pad and information paperon the website
The chart was developed independently by the National Asthma Council Australia, with untied support from Mylan Health and Care Pharmaceuticals.
Health professionals can find information on managing allergic rhinitis in people with asthma, and on managing asthma during the COVID-19 pandemic in the Australian Asthma Handbook.
For further information or an interview with a National Asthma Council Australia spokesperson, please contact:
Lelde McCoy, The Reputation Group.
Mobile: 0417 362 768